Skip to main content
AMP 2025 Annual Meeting & Expo Main banner
Final Program


    Maryellen de Mars

    Medical Device Innovation Consortium (MDIC)

    Maryellen de Mars, Ph.D. is the Head of the Center for Manufacturing Innovation and Quality at the Medical Device Innovation Consortium (MDIC). In this role, she leads collaborative initiatives to advance excellence in medical device quality, design, and manufacturing through developing best practices and innovative resources.
    Prior to joining MDIC, Dr. de Mars spearheaded regulatory approval and market launch efforts for a novel molecular COVID-19 detection platform at Integrated Nano-Technologies, Inc. (INT). Before that, she served as Vice President of the Standards Resource Center at ATCC, where she led standards development and services supporting life science R&D. During her tenure at ATCC, she also contributed as an industry representative to early MDIC Science of Standards (SRS) initiatives.
    Dr. de Mars has held several leadership roles across the diagnostics and life sciences sectors, including Chief Operating Officer and VP of Clinical Operations at USDS, Inc., where she oversaw independent evaluations of molecular diagnostic tests. At the Critical Path Institute (C-Path), she directed clinical biomarker programs to enhance the development of companion diagnostics. She also served as Executive Director of Genomics Services and Director of the Biorepository at Gene Logic, Inc., and led product marketing and business development at Life Technologies (now Thermo Fisher Scientific).
    Dr. de Mars earned her B.A. from Smith College and her Ph.D. in Virology from the University of Texas. She completed postdoctoral training in transcriptional regulation at The Johns Hopkins University.

    Disclosure information not submitted.

    Presentation(s):